Daniel Wendling
0000-0002-4687-5780
CHRU de Besançon
13 papers found
Refreshing results…
Standardized reporting for systematic global evaluation of axial spondyloarthritis: An evidence-based and consensus-driven initiative
Évaluation globale standardisée systématique des rhumatismes inflammatoires chroniques : intérêts et limites
Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort
Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
Ten-Year Clinical Outcome of recent-onset Axial Spondyloarthritis: results from the DESIR inception Cohort
Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries
Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis
Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
Dr. Kiltz, et al reply
Uveitis occurrence in early inflammatory back pain. Five years data from the prospective French nationwide DESIR cohort
ASAS Health Index: The “All in One” for Spondyloarthritis Evaluation?
Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients
Missing publications? Search for publications with a matching author name.